Analyzing the Major Pharmaceutical Markets
| Publication Date | June 2007 |
|---|---|
| Publisher | Aruvian Research |
| Product Type | Report |
| Pages | 100 |
| ISBN Number | not applicable |
| Product Code | ARU00225 |
Summary
The Global Pharmaceutical Industry is the influencer and supplement of the health index of world populations. It is with the constant, untiring and accelerated efforts of this industry's constituents which ensure that countries can find health solutions for their citizens which are backed by world class R& D and provide the same at reasonable costs.
The global pharmaceutical industry meets such regulatory and social challenges by developing country specific studies or coming up with drug lines for continents. This leads to proliferation of global R&D effort and technology transfer initiatives which lead to long term gains for the target countries. Such efforts boost the local economies by bringing in investment and helping in raising the knowledge employment ratios globally.
Aruvian Research's report - Analyzing the Major Pharmaceutical Markets - globally is a complete ready country reckoner which offers the analyst at one glance a complete understanding of the commercially active major pharma markets of the world.
These markets are analyzed in the report in terms of their industry statistics, segmentation, player market shares and other market dynamics. The report gives an update on country pharma markets in detail and covers markets like Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Norway, Poland, Russia, South Africa, South Korea, Spain, Sweden, Taiwan, The Netherlands, United Kingdom and the United States.
A complete understanding of the global pharmaceutical industry is possible only after delving deeper into the dynamics of countries which influence this industry by contributing in finance, knowledge or other initiatives.
Content
- A. Executive Summary
- B. Introduction to the Global Pharmaceutical Industry
- B.1 Industry Definition
- B.2 Profiling the Industry
- B.3 Market Segments
- B.4 Competition in the Industry
- B.5 Market Forecast
- C. Australia
- C.1 Industry Overview & Statistics
- C.2 Market Segments & Market Share
- C.3 Competition in the Industry
- C.4 Future Outlook
- D. Belgium
- D.1 Industry Overview & Statistics
- D.2 Market Segments & Market Share
- D.3 Competition in the Industry
- D.4 Future Outlook
- E. Brazil
- E.1 Industry Overview & Statistics
- E.2 Market Segments & Market Share
- E.3 Competition in the Industry
- E.4 Future Outlook
- F. Canada
- F.1 Industry Overview & Statistics
- F.2 Market Segments & Market Share
- F.3 Competition in the Industry
- F.4 Future Outlook
- G. China
- G.1 Industry Overview & Statistics
- G.2 Market Segments & Market Share
- G.3 Competition in the Industry
- G.4 Future Outlook
- H. Czech Republic
- H.1 Industry Overview & Statistics
- H.2 Market Segments & Market Share
- H.3 Competition in the Industry
- H.4 Future Outlook
- I. Denmark
- I.1 Industry Overview & Statistics
- I.2 Market Segments & Market Share
- I.3 Competition in the Industry
- I.4 Future Outlook
- J. France
- J.1 Industry Overview & Statistics
- J.2 Market Segments & Market Share
- J.3 Competition in the Industry
- J.4 Future Outlook
- K. Germany
- K.1 Industry Overview & Statistics
- K.2 Market Segments & Market Share
- K.3 Competition in the Industry
- K.4 Future Outlook
- L. Hungary
- L.1 Industry Overview & Statistics
- L.2 Market Segments & Market Share
- L.3 Competition in the Industry
- L.4 Future Outlook
- M. India
- M.1 Industry Overview & Statistics
- M.2 Market Segments & Market Share
- M.3 Competition in the Industry
- M.4 Future Outlook
- N. Italy
- N.1 Industry Overview & Statistics
- N.2 Market Segments & Market Share
- N.3 Competition in the Industry
- N.4 Future Outlook
- O. Japan
- O.1 Industry Overview & Statistics
- O.2 Market Segments & Market Share
- O.3 Competition in the Industry
- O.4 Future Outlook
- P. Mexico
- P.1 Industry Overview & Statistics
- P.2 Market Segments & Market Share
- P.3 Competition in the Industry
- P.4 Future Outlook
- Q. Norway
- Q.1 Industry Overview & Statistics
- Q.2 Market Segments & Market Share
- Q.3 Competition in the Industry
- Q.4 Future Outlook
- R. Poland
- R.1 Industry Overview & Statistics
- R.2 Market Segments & Market Share
- R.3 Competition in the Industry
- R.4 Future Outlook
- S. Russia
- S.1 Industry Overview & Statistics
- S.2 Market Segments & Market Share
- S.3 Competition in the Industry
- S.4 Future Outlook
- T. South Africa
- T.1 Industry Overview & Statistics
- T.2 Market Segments & Market Share
- T.3 Competition in the Industry
- T.4 Future Outlook
- U. South Korea
- U.1 Industry Overview & Statistics
- U.2 Market Segments & Market Share
- U.3 Competition in the Industry
- U.4 Future Outlook
- V. Spain
- V.1 Industry Overview & Statistics
- V.2 Market Segments & Market Share
- V.3 Competition in the Industry
- V.4 Future Outlook
- W. Sweden
- W.1 Industry Overview & Statistics
- W.2 Market Segments & Market Share
- W.3 Competition in the Industry
- W.4 Future Outlook
- X. Taiwan
- X.1 Industry Overview & Statistics
- X.2 Market Segments & Market Share
- X.3 Competition in the Industry
- X.4 Future Outlook
- Y. The Netherlands
- Y.1 Industry Overview & Statistics
- Y.2 Market Segments & Market Share
- Y.3 Competition in the Industry
- Y.4 Future Outlook
- Z. United Kingdom
- Z.1 Industry Overview & Statistics
- Z.2 Market Segments & Market Share
- Z.3 Competition in the Industry
- Z.4 Future Outlook
- AA. United States
- AA.1 Industry Overview & Statistics
- AA.2 Market Segments & Market Share
- AA.3 Competition in the Industry
- AA.4 Future Outlook
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
PRINT/CD-ROM:Despatched within 2 to 4 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















